As the therapeutic mechanism of the anti-PD-1 antibody was to block the PD-1/PD-L1 pathway to enhance the antitumor T-cell effector activity, we established the xenograft mice model of human colorectal cancer [25]. Here, CD274 is linked to colorectal cancer.